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Abstract
Objectives: Sex hormones have long been considered to play an influential role on
periodontal tissues, bone turnover rate, wound healing and periodontal disease
progression. The objectives of this review article are to (1) address the link between
sex hormones and the periodontium, (2) analyse how these hormones influence the
periodontium at different life times and (3) discuss the effects of hormone
supplements/replacement on the periodontium.
Materials and Methods: Two autonomous searches were performed in
English language utilizing Medline, Premedline and Pubmed as the online
databases. Publications up to 2002 were selected and further reviewed. In addition,
a manual search was also performed including specific related journals
and books.
Results: It is certain that sexual hormones play a key role in periodontal disease
progression and wound healing. More specifically, these effects seem to differentiate
by gender as well as lifetime period. In addition, the influence of sex hormones can be
minimized with good plaque control and with hormone replacement.
Conclusion: Despite profound research linking periodontal condition with sex
hormones kinetics, more definitive molecular mechanisms and therapy still remain to
be determined.
Key words: hormones; estrogen; periodontium;
pregnancy; periodontal diseases
Accepted for publication 3 September 2002
Bacterial plaque has been established as
the primary etiologic factor for the
initiation of periodontal disease (Loe
et al. 1965). However, it has also been
shown that without a susceptible host
the periodontal pathogens are necessary
but not sufficient for disease to occur.
Hence, the systemic factors/conditions
of the host must be understood since
they may affect disease prevalence,
progression, and severity (Lang et al.
1983). Among these, sexual hormones
have been suggested as important mod-
ifying factors that may influence the
pathogenesis of periodontal diseases
(Mariotti 1994, Parkar et al. 1998b,
Hofbauer & Heufelder 2001).
Hormones are specific regulatory mo-
lecules that modulate reproduction,
growth and development, maintenance
of the internal environment, as well as
energy production, utilization, and sto-
rage (Mariotti 1994). Hormonal effects
reflect physiological/pathological changes
in almost all types of tissues of the body.
Targets for a number of hormones such
as androgens, estrogen, and progesterone
have also been localized in periodontal
tissues (Gornstein et al. 1999). Conse-
quently, systemic endocrine imbalances
may have an important impact in period-
ontal pathogenesis.
Researchers have shown that changes
in periodontal conditions might be asso-
ciated with variations in sex hormone
levels. This association is evident in the
recent periodontal disease classification
(Armitage 1999), which includes the
following hormone-related disease cate-
gories: puberty-associated gingivitis,
menstrual cycle-associated gingivitis and
pregnancy-associated gingivitis. There-
fore, the goal of this review paper is to
discuss how sex hormones may influence
the periodontium and periodontal wound/
bone healing.
Steroid Sex Hormones
Because of their complexity and diver-
sity, hormones are difficult to arrange
into discrete groups, although they can
be divided into four subgroups based
upon their chemical structure – steroids,
glycoproteins, polypeptides, and amines.
Steroid sex hormones are derived
from cholesterol and as a common
structure they have three rings of six
carbon atoms. They are believed to play
an important role in the maintenance of
the skeletal integrity, including the
alveolar bone. The steroid sex hormones
such as estrogen and estradiol have been
J Clin Periodontol 2003; 30: 671–681 Copyright r Blackwell Munksgaard 2003
Printed in Denmark. All rights reserved
known for their effect on bone mineral
metabolism. Other bone turnover-re-
lated hormones include progesterone,
testosterone and dihydrotestosterone,
androstenedione, dihydroepiandrostene-
dione, and sex hormone-binding globu-
lin (Katz & Epstein 1993). Among
these, estrogens, progesterone, and tes-
tosterone have been most linked with
periodontal pathogenesis and therefore
will be described in detail in the paper.
Estrogen and progesterone
Estrogen and progesterone are responsi-
ble for physiological changes in women
at specific phases of their life, starting in
puberty. Estrogen induces several of the
pubertal developmental changes in fe-
males, and progesterone acts synergisti-
cally with estrogen to control the
menstrual cycle and to inhibit follitroppin
secretion by the anterior pituitary gland
(Amar & Chung 1994). Both hormones
are also known to promote protein
anabolism and growth (Soory 2000a).
Both hormones have significant bio-
logical actions that can affect different
organ systems including the oral cavity
(Lundgren 1973a, b, Lundgren et al.
1973, Lopatin et al. 1980, Pack &
Thomson 1980, Sooriyamoorthy &
Gower 1989a, Ojanotko-Harri et al.
1991, Mariotti 1994). Specifically, es-
trogens can influence the cytodifferen-
tiation of stratified squamous epithelium
as well as the synthesis and mainte-
nance of fibrous collagen (Amar &
Chung 1994). Estrogen receptors found
in osteoblast-like cells provide a me-
chanism for the direct action on bone
(Klinger & Sommer 1978, Aufdemorte
& Sheridan 1981, Eriksen et al. 1988,
Komm et al. 1988). These receptors
were also located in periosteal fibro-
blasts, scattered fibroblasts of the lami-
na propria (Aufdemorte & Sheridan
1981), and periodontal ligament (PDL)
fibroblasts (Nanba et al. 1989a), proving
the direct action of sex hormones on
different periodontal tissues.
Clinically, estrogen-sufficient pa-
tients have been reported to have more
periodontal plaque without increased
gingival inflammation when compared
to patients with deficient levels of
estrogens (Reinhardt et al. 1999). This
suggests that inflammatory mediators
may be affected by estrogen hormone
level, which may be attributed to the
production of prostaglandins (PGs) by
the involvement of estradiol and pro-
gesterone. It is, therefore, speculated
that normal circulating estrogen levels
might be essential for periodontal pro-
tection. In fact, the amount of circulat-
ing estradiol seems to be inversely
correlated with the prevalence of peri-
odontal disease (Plancak et al. 1998).
Other effects of the estrogens on the
periodontium are listed in Table 1.
Progesterone is another sex hormone
that has also been demonstrated to have
direct effects on the periodontium
(Table 2). Experimental, epidemiologic,
and clinical data have demonstrated that
progesterone is active in bone metabo-
lism and may play an important role in
the coupling of bone resorption and
bone formation (Dequeker et al. 1977,
Dequeker & De Muylder 1982, Lobo et
al. 1984, Gallagher et al. 1991). Studies
have shown that progesterone may exert
its action directly on bone by engaging
osteoblast receptors or indirectly by
competing for a glucocorticoid receptor
(Feldman et al. 1975, Chen et al. 1977).
Androgens (testosterone)
Androgens are hormones responsible
for masculinization. Testosterone can
be produced in the adrenal cortex,
although the one from the testes is the
most active form (Ganong 1997). Its
secretion is regulated by ACTH and by
pituitary adrenal androgen-stimulating
hormone. The adrenal androgen andros-
tenedione is converted to testosterone
and to estrogens in the circulation and re-
presents an important source of estrogens
in men and in postmenopausal women.
Specific receptors for this hormone
have been isolated in the periodontal
tissues (Wilson & Gloyna 1970). Inter-
estingly, the number of receptors in
fibroblasts tends to increase in inflamed
or overgrown gingiva (Ojanotko et al.
1980). It is believed that an increasing
matrix synthesis occurs on periodontal
cells under testosterone influence (Oja-
notko et al. 1980, Kasperk et al. 1989,
Sooriyamoorthy & Gower 1989a).
Testosterone has also been associated
with bone metabolism, playing a role in
the maintenance of bone mass (Morley
2000). A study performed on a group of
men who were castrated for sexual
offences showed that bone density
suffered a rapid decrease that was
sustained for a number of years after
castration (Stepan et al. 1989). Kasperk
et al. (1997) observed that both gonadal
androgen dihydrotesterone (DHT) and
adrenal androgen dehydroepiandroster-
one (DHEA) have a positive impact on
bone metabolism, by stimulating bone
cell proliferation and differentiation. A
very effective way to analyze the effect
of androgens on bone metabolism is the
evaluation of the presence of biochem-
ical markers of bone remodeling on
bone tissue under the influence of those
hormones. One of the bone remodeling
markers that has been used for this
objective is osteoprotegerin (OPG),
which is a secreted decoy receptor that
inhibits osteoclast formation and activa-
tion by neutralizing its cognate ligand
(Kong et al. 1999, Teitelbaum 2000).
This OPG action has been associated
with a reduction in the loss of bone
mineral density that is observed during
periodontal disease progression (Kong
et al. 1999). Szulc et al. (2001) found
that serum concentrations of OPG
increased significantly with age, and
Table 1. Effects of estrogen in the Periodontium
 increased amount of plaque with no increase of gingival inflammation (Reinhardt et al. 1999)
 inhibit proinflammatory cytokines release by human marrow cells (Gordon et al. 2001)
 reduce T-cell-mediated inflammation (Josefsson et al. 1992)
 suppress leukocyte production from the bone marrow (Josefsson et al. 1992, Cheleuitte et al.
1998)
 inhibit PMN chemotaxis (Ito et al. 1995)
 stimulate PMN phagocytosis (Hofmann et al. 1986)
Table 2. Effects of progesterone in the periodontium
 increase production of prostaglandins
(self-limiting process) (ElAttar 1976b, Smith et al. 1986)
 increase polymorphonuclear leukocytes and PGE2 in the GCF
 reduce glucocorticoid anti-inflammatory effect (Feldman et al. 1975, Chen et al. 1977)
 altered collagen and noncollageneous protein synthesis (Willershausen et al. 1991)
 alter PDL fibroblast metabolism (Nanba et al. 1989b, Sooriyamoorthy & Gower 1989b,
Tilakaratne & Soory 1999a, b)
 increase vascular permeability (Abraham-Inpijn et al. 1996)
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were positively correlated with free
testosterone index and free estradiol
index. They concluded that age as well
as androgen and estrogen status are
significant positive determinants,
whereas parathyroid hormone (PTH) is
a negative determinant of OPG serum
levels in men (Szulc et al. 2001). These
data suggest that OPG may be an
important paracrine mediator of bone
metabolism in elderly men and high-
light the role of androgens in the
homeostasis of the male skeleton.
Studies have also examined how the
function of these hormones is controlled
or regulated in the periodontium, look-
ing specifically at the influence of
different growth factors on the stimula-
tion of DHT synthesis. Kasasa & Soory
(1995) found significant stimulation of
DHT synthesis by insulin-like growth
factor (IGF) in gingiva and cultured
fibroblasts. This finding suggests a
possible mechanism of mediating in-
flammatory repair via the androgen
metabolic pathway. The same authors
later investigated the effects of inter-
leukin-1 (IL-1) on the metabolism of
androgens from chronically inflamed
human gingival tissue (HGT) and
PDL. In response to IL-1, HGT demon-
strated a two-fold increase in DHT
synthesis and a 3.5-fold increase in 4-
androstenedione formation over control
gingival tissue; the PDL showed a 9-
fold increase in DHT synthesis in
response to IL-1 and a 6-fold increase
in 4-androstenedione formation over
control ligament tissue. The observation
of increased androgen metabolic capa-
city of PDL over HGT in response to
IL-1 insult might be relevant to repair
processes during inflammatory period-
ontal disease (Kasasa & Soory 1996).
Androgens also have a reciprocal
effect on other important mediators of
inflammation, more specifically on IL-6.
This cytokine plays a major role in
tissue damage during periodontal dis-
eases, and is secreted by many cell
types, including oral fibroblasts. In
1998, Parkar et al. investigated whether
DHT affects the expression and regula-
tion of IL-6 in gingival fibroblasts.
Using ELISA, they observed that in-
creasing DHT concentrations progres-
sively reduced IL-6 production by
gingival cells from both normal indivi-
duals and patients with gingival inflam-
mation and gingival hyperplasia (Parkar
et al. 1998a). Similar results were also
reported by Gornstein et al. (1999).
They found androgen receptors to be
present in both human gingival and
periodontal ligament fibroblasts, and
reduced the production of IL-6 in the
presence of androgens. It was suggested
that elevated levels of androgens, more
specifically testosterone and dihydrotes-
tosterone, could affect the stromal cell
response to an inflammatory challenge
through downregulation of IL-6 produc-
tion.
An in vitro study analyzed the
relationship between various concentra-
tions of male testosterone and the
formation of radioactive PGs from
arachidonic acid by gingival homoge-
nate (ElAttar et al. 1982). They reported
that testosterone had inhibitory effects
in the cyclooxygenase pathway of
arachidonic acid metabolism in the
gingiva, and speculated that this sex
hormone may have anti-inflammatory
effects in the periodontium. These
steroids can exert an anabolic effect on
the tissues even when their anabolic
capacity is decreased, as is the case
during inflammation. These findings
support the concept that androgens
may have a limiting effect on period-
ontal inflammation during periodontal
disease progression. From the research
reported above, it can be concluded that
the production of androgens is stimu-
lated by the presence of proinflamma-
tory cytokines commonly found on
periodontally diseased tissues and is
downregulated by proinflammatory cy-
tokines concentration as well as the
concentration of prostaglandins.
Table 3 lists the effects of androgens
on the periodontium. Overall, androgens
may protect the periodontium via a
positive anabolic effect on periodontal
cells, a negative effect on the production
and presence of mediators of inflamma-
tion, and an inhibitory effect on osteo-
clastic function.
Factors Influencing Sex Hormone
Effects on the Periodontium
Several factors may also influence how
sex hormones affect the periodontium.
These include gender, age, and hormone
supplements. These interactions will be
thoroughly discussed in the following
sections.
Gender
It is well understood that gender plays
an important role in changes of the bone
density throughout the entire skeleton. It
is also known that women are much
more affected than men (e.g. osteoporo-
sis). Lau et al. (2001) reported that 80%
of the osteoporotic patients are female,
correlating with the higher frequency of
hip fractures in females, who are also
more likely to experience hormonal
imbalance throughout their lives than
males. In addition, when the influence
of gender on periodontal disease was
studied, females were considered for
several years to be more affected than
males (Marques et al. 2000, Novaes Jr
& Novaes 2001), although contradicting
data have been reported (Novaes Jr et al.
1996, Ship & Beck 1996, Albandar et
al. 1999, Novaes Jr & Novaes 1999,
Pihlstrom 2001, Yuan et al. 2001a, b).
This disparity seems to be simply
correlated with the fact that females
are more likely to seek dental care than
males (Hart et al. 1992, Novaes Jr &
Novaes 2001). One observation that
supports this notion is the presence of
the same quantity and quality of sub-
gingival bacteria, which is the most
important risk factor for periodontal
disease, in both men and women
(Schenkein et al. 1993). Overall, the
similarities/differences of periodontal
pathogenesis among different sexes still
requires much clarification. The role of
the sex hormones in wound healing
raises another question of how the
endocrine system influences this dis-
ease, since sexual hormones differ with
gender.
Regarding periodontal anatomic dif-
ferences between genders, when the
shape and height of the residual alveolar
ridge were compared, it was found that
the residual ridge in women is lower
than that in men (Hirai et al. 1993). This
Table 3. Effects of androgens in the periodontium
 stimulate matrix synthesis by osteoblasts and periodontal ligament fibroblasts (Ojanotko et al.
1980, Kasperk et al. 1989, Sooriyamoorthy & Gower 1989c)
 stimulate osteoblast proliferation and differentiation (Kasperk et al. 1997, Morley 2000)
 reduce IL-6 production during inflammation (Parkar et al. 1998b, Gornstein et al. 1999)
 inhibit prostaglandin secretion (ElAttar et al. 1982)
 Enhance OPG concentration (Szulc et al. 2001)
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might be associated with the decreased
amount of circulating estrogen found in
women during menopause, since this
condition is associated with a higher
frequency of alveolar bone height loss,
as well as decreased crestal and sub-
crestal bone density (Payne et al. 1999).
Those effects seem to be correlated with
hormone concentrations and not to the
increased susceptibility of the period-
ontal tissues, since it has been shown
that males and females tend to have the
same amount of receptors for sex
hormones in periodontal tissues (South-
ren et al. 1978).
Age
The biological changes on the period-
ontal tissues during different time points
such as puberty, the menstrual cycle,
pregnancy, menopause, and oral contra-
ceptive use have heightened interest in
the relationship between steroid sex
hormones and the health of the period-
ontium. Females seem to be more prone
to hormone imbalance than males and
therefore have been more extensively
studied. It is important, however, to note
that males also suffer from these varia-
tions (Morley 2000).
Puberty
Puberty is a complex process of sexual
maturation resulting in an individual
capable of reproduction (Ford & D’Oc-
chio 1989, Halpern et al. 1998). It is
also responsible for changes in physical
appearance and behavior (Buchanan et
al. 1992, Angold & Worthman 1993,
Angold et al. 1999) that are related with
increased levels of the steroid sex
hormones, testosterone in males and
estradiol in females.
During puberty, the production of sex
hormones increases to a level that
remains constant for the entire normal
reproductive period. A peak prevalence
of gingivitis was determined at 12 years,
10 months in females and 13 years, 7
months in males, which is consistent
with the onset of puberty (Sutcliffe
1972). Changes in hormone levels have
been related with an increased preva-
lence of gingivitis followed by remis-
sion (Massler et al. 1950, Curilovic et
al. 1958, Sutcliffe 1972, Daniell 1983),
a situation that is not necessarily
associated with an increase in the
amount of dental plaque (Sutcliffe
1972).
The subgingival microflora is also
altered during this period since the
bacterial counts increase in number,
and there is a prevalence of certain
bacterial species such as Prevotella
intermedia (Pi) and Capnocytophaga
species (Yanover & Ellen 1986, Gus-
berti et al. 1990). Pi has been shown to
possess the ability to substitute estrogen
and progesterone for menadione (vita-
min K) as an essential growth factor
(Kornman & Loesche 1982). This may
explain the association between in-
creased estrogen concentrations and
the elevated counts of Pi. On the other
hand, Capnocytophaga species, which
often increase during puberty, have
been associated with the increased
bleeding tendency observed during this
period of time (Gusberti et al. 1990).
Mombelli et al. (1990) evaluated long-
itudinal changes, during a period of 4
years, in the composition of the sub-
gingival microbiota of children between
11 and 14 years of age. They observed
that children who developed marked
and sustained puberty gingivitis had
higher frequencies of spirochetes, Cap-
nocytophaga sp., Actinomyces viscosus,
and Eikenella corrodens than the chil-
dren without puberty gingivitis. They
also noted that a resurgence of Pi was
correlated with a high bleeding ten-
dency in these patients.
The data strongly indicate that with
the influence of sex hormones, children
in puberty experience an exaggerated
gingival inflammatory response to pla-
que. Table 4 lists the clinical and
microbiological changes observed in
the periodontium during puberty.
Menstrual cycle
The menstrual cycle is controlled by the
secretion of sex hormones over a 25–30-
day period and is responsible for
continued ovulation until menopause
(Ganong 1997, McCartney et al.
2002). In humans, the menstrual cycle
can be divided into two phases: a
follicular or proliferative phase, and a
luteal or secretory phase. During the
first phase, there is an increase in
estrogen levels. At the same time, the
luteinizing hormone stimulates proges-
terone secretion and ovulation. After
ovulation, the luteal phase is character-
ized by an increase in progesterone and
estrogen secretion. At the end of this
phase, and if fertilization has not
occurred, the plasma levels of proges-
terone and estradiol decline because of
the demise of the corpus luteum (Laufer
et al. 1982).
Generally, the periodontium does not
exhibit evident changes during the
menstrual cycle. Nonetheless, two dif-
ferent clinical findings have been ob-
served in the oral cavity: gingival
bleeding and increased production of
gingival exudate (Kribbs & Chesnut
1984, Kribbs et al. 1989, Kribbs 1990,
1992, Grodstein et al. 1996a, b). In
addition, ulcerations of the oral mucosa
and vesicular lesions have also been
Table 4. Clinical and microbiologic changes in the periodontium
During puberty
 enhanced blood circulation in the end terminal capillary loops and associated increased
prevalence of gingivitis/bleeding tendency (Muhlemann 1948, Massler et al. 1950,
Curilovic et al. 1958, Sutcliffe 1972, Daniell 1983)
 higher bacterial counts (especially Prevotella intermedia (Pi) and Capnocytophaga species)
(Kornman & Loesche 1982, Mombelli et al. 1990, Mariotti 1994)
During pregnancy
 increased tendency for gingivitis and larger gingival probing depths (Loe & Silness 1963,
Silness & Loe 1964, Miyazaki et al. 1991, Robinson & Amar 1992, Machuca et al. 1999,
Soory 2000a) and periodontitis (Robinson & Amar 1992)
 increased susceptibility to infection (Cohen et al. 1969, Brabin 1985)
 decreased neutrophil chemotaxis and depressed antibody production (Sooriyamoorthy &
Gower 1989b, Raber-Durlacher et al. 1991, Raber-Durlacher et al. 1993)
 increased numbers of periodontopathogens (especially Porphyromonas gingivalis and Pi)
(Kornman & Loesche 1980, Tsai & Chen 1995)
 increased synthesis of PGE2 (ElAttar 1976b)
Table 5. Effect of osteoporosis upon periodontium
 Poor wound healing: less attachment formation (von Wowern et al. 1994)
 Reduced bone mineral content in the jaws (von Wowern et al. 1994, Payne et al. 1999)
 Increase of periodontosis and tooth loss (Mittermayer et al. 1998)
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noted (Segal et al. 1974) in the luteal
phase of the menstrual cycle, although
the incidence is low (Segal et al. 1974,
Ferguson et al. 1978, 1984). However,
the specific mechanism of how steroid
sex hormones influence vesicle/ulcera-
tion formation remains to be determined
(Mariotti 1994).
Pregnancy
Some of the most remarkable endocrine
alterations accompany pregnancy. Dur-
ing this period, both progesterone and
estrogen are elevated due to continuous
production of these hormones by the
corpus luteum. By the end of the third
trimester, progesterone and estrogen
reach peak plasma levels of 100 and
6 ng/ml, respectively, which represent
10 and 30 times the levels observed
during the menstrual cycle (Zachariasen
1989, Amar & Chung 1994, Mariotti
1994).
Susceptibility to infections (e.g. per-
iodontal infection) increases during
early gestation due to alterations in the
immune system (Cohen et al. 1969,
Brabin 1985) and can be explained by
the hormonal changes observed during
pregnancy (Hansen 1998, Smith 1999),
suppression on T-cell activity (Priddy
1997, Taylor et al. 2002), decreased
neutrophil chemotaxis and phagocyto-
sis, altered lymphocyte response and
depressed antibody production (Soor-
iyamoorthy & Gower 1989a, Raber-
Durlacher et al. 1991, 1993, Zacharia-
sen 1993), chronic maternal stress
(Culhane et al. 2001), and even nutri-
tional deficiency associated with in-
creased nutritional demand by both the
mother and the fetus (Wellinghausen
2001). Consequently, increased suscept-
ibility for certain infections such as
Helicobacter pilori (Lanciers et al.
1999), Coxiella burnetii, Listeria mono-
cytogenes, Toxoplasma gondii (Smith
1999), and virus infections (e.g. hepati-
tis E virus rubella, herpes, and human
papilloma virus) has also been observed
and reported (Priddy 1997).
These immunologic changes might
also be responsible for periodontal
pathologic conditions observed during
pregnancy such as pregnancy gingivitis
(Loe & Silness 1963, Silness & Loe
1964, Miyazaki et al. 1991, diLauro &
Tarturo 1971, Machuca et al. 1999,
Soory 2000a), pregnancy granuloma,
periodontitis, and dental caries (diLauro
& Tarturo 1971). The increased synth-
esis of PGE2 observed when estradiol
and progesterone are present in higher
concentrations, such as occurs during
pregnancy (ElAttar 1976a), may also
contribute to these pathologic changes
(Offenbacher et al. 1984, 1986). On the
other hand, periodontal pathogens such
as Pi and Porphyromonas gingivalis
(Pg) can also use female sex hormones
such as progesterone or estradiol as a
source of nutrients. These bacteria are
generally increased in the gingival
crevicular fluid of pregnant women, a
situation that is positively correlated
with the severity of pregnancy gingivitis
(Kornman & Loesche 1980, Tsai &
Chen 1995). These microbiological
shifts usually do not last postpartum
(Raber-Durlacher et al. 1994). None-
theless, (Jonsson et al. 1988) found that
Pi remains consistent even after the end
of the pregnancy.
Aside from the transient increases in
bleeding (Arafat 1974, Miyazaki et al.
1991), gingivitis, larger gingival prob-
ing depths (Hugoson 1971, Miyazaki et
al. 1991), increased gingival crevicular
fluid flow (Hugoson 1971), and the
subgingival microbial shift, pregnant
women in good heath are unlikely to
experience any significant gingival re-
sponses that would have serious clinical
implications (Amar & Chung 1994).
Menopause and postmenopause
In the premenopausal women, the
principal circulating estrogen is 17b-
estradiol (Katz & Epstein 1993). As
women approach menopause, the levels
of estrogen begin to drop mainly during
the late follicular and luteal phase of the
menstrual cycle (Sherman & Korenman
1975). As a result of this physiologic
situation, irregular cycles start to occur.
Frequently, the time frame between
regular cycles and the cessation of
menstrual periods, called perimenopau-
sal transition, is 2–7 years (Treloar
et al. 1970). During this period, the
concentration of circulating estrogen
decreases while follicle-stimulating hor-
mone (FSH) and luteinizing hormone
(LH) concentrations increase (Monroe
& Menon 1977). Consequently, the
effects of estrogen listed in Table 1
are reduced, therefore compromising
the anti-inflammatory effect of this
hormone on the periodontium.
Progesterone is another sex hormone
that may play an important role in bone
metabolism during pre- and postmeno-
pause (Katz & Epstein 1993). It is
believed that ovarian deficiency and
associated alterations, but not aging,
are the predominant causes of bone loss
during the first two decades after
menopause (Richelson et al. 1984).
Researches have shown that progester-
one may compete with glucocorticoids
for an osteoblast receptor and inhibit the
glucocorticoid-induced osteoporosis.
Therefore, postmenopausal bone density
reduction may be the result of a
combination of the inhibition of osteo-
clast downregulation by reduced estro-
gen and the increased cortisol inhibition
of osteoblasts via the reduction of
competition with progesterone (Katz &
Epstein 1993).
Menopause also affects the concen-
tration of circulating androgens. Before
menopause, 50% of the circulating
androstenedione is derived from the
ovaries and 50% from the adrenals.
With the ovarian failure that typically
occurs with menopause, the concentra-
tion of circulating androgens is reduced
by about 50% (Judd 1976). It has been
suggested that the peripheral conversion
of androgens to estrogens may be the
main factor for protecting bone (Katz &
Epstein 1993), since, as previously
mentioned, estrogens have an inhibitory
effect on osteoclastic action. Testoster-
one was also found to be positively
correlated with bone density, a finding
that is supported by the evidence of low
concentrations in osteoporotic patients
(Davidson et al. 1982, Steinberg et al.
1989).
A number of studies have linked
menopause with some periodontal con-
ditions, although the different methods
applied to assess osteoporosis, alveolar
bone loss, and periodontitis make that
literature difficult to analyze. As sug-
gested, osteoporosis is responsible for
less crestal alveolar per unit volume, a
condition that may promote quicker
bone loss when encountered with infec-
tions such as periodontal infections
(Wactawski-Wende et al. 1996).
It has been reported that the inci-
dence of periodontitis correlates with
signs of generalized osteoporosis, and
lower bone density of the mandible with
an increased incidence of periodontal
disease (Groen et al. 1968, Klemetti et
al. 1994, Krall et al. 1994, Krall 2001,
Wactawski-Wende 2001), although
other studies do not show consistent
relationships between those aspects
(Kribbs 1990, Elders et al. 1992).
Reinhardt et al. (1999) reported that
patients with estrogen deficiency
showed more bleeding on probing
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(BOP) and a higher frequency of
X2mm of clinical attachment loss than
patients without estrogen deficiency.
They then speculated that estrogen
supplementation is important in redu-
cing gingival inflammation and limiting
the frequency of clinical attachment loss
in osteopenic/osteoporotic women in
early menopause. However, when Win-
grove et al. (1979) compared gingival
biopsies taken from postmenopausal
females and from younger women with
regular menses, no significant differ-
ences in the gingival tissues associated
with changes in the levels of sex
hormones were found.
The same correlation between estro-
gen deficiency, osteopenia/osteoporosis,
and the prevalence of tooth loss was
also reported (Daniell 1983, Kribbs et
al. 1989, Elders et al. 1992, von
Wowern et al. 1994, Paganini-Hill
1995a, Grodstein et al. 1996a,, Mitter-
mayer et al. 1998, Reinhardt et al.
1999). An important idea that should
be kept in mind is that in many of these
cases, tooth loss might be influenced by
factors other than periodontal disease.
The severity of osteoporosis was
found to be statistically significantly
associated with the height of the re-
sidual alveolar ridge (Hirai et al. 1993).
Payne et al. (1999) in a 2-year long-
itudinal study examined alveolar bone
height and density changes in osteo-
porotic/osteopenic women compared
with women with normal lumbar spine
bone mineral density (BMD). In total,
38 postmenopausal women with a past
history of periodontal disease on a 3- or
4-month periodontal maintenance inter-
val were monitored; 21 had normal
bone mineral density and 17 had
diagnosed osteoporosis. Results from
this study indicated that osteoporotic/
osteopenic women exhibited a higher
frequency of alveolar bone height loss,
as well as crestal and subcrestal density
loss when compared to women with
normal bone density. This corresponds
to the decreased amount of circulating
estrogen present in the osteoporotic/
osteopenic women.
Even though osteoporosis has been
considered a risk for periodontal disease
(Page & Beck 1997, Krejci & Bissada
2000, Pihlstrom 2001), many authors
still question if the associations reported
above are just concomitant findings or if
osteoporotic patients have an increased
susceptibility to periodontal disease,
which would explain the increased
incidence of edentulous patients and
more severe forms of periodontal dis-
ease. In 1997, Streckfus et al. studied
the relationship among alveolar bone
loss, alveolar bone density, second
metacarpal density, salivary and gingi-
val crevicular fluid IL-6, and IL-8
concentrations in premenopausal and
postmenopausal healthy women receiv-
ing estrogen therapy. Other than obser-
ving that postmenopausal women on
estrogen therapy had more alveolar
bone loss, more missing teeth, and
reduced alveolar and second metacarpal
bone density than premenopausal wo-
men, the authors also noticed that
postmenopausal women on estrogen
therapy had higher salivary IL-6 con-
centrations than premenopausal women.
From this study it was concluded that
levels of bone resorptive cytokines in
saliva may be secondary to changes in
menopausal status, and that these
changes may predispose loss of alveolar
bone with resultant loss of teeth (Streck-
fus et al. 1997).
Although research shows a linkage
between menopause and increased signs
of periodontal disease and a reduction in
alveolar bone height, it is important to
note that both menopausal and postme-
nopausal women who are in good
gingival health should not be considered
to be at an increased risk of periodontal
disease, although these physiologic con-
ditions may affect the severity of the
present disease (Amar & Chung 1994).
Hormone replacement
As addressed above, females experience
hormonal changes under both physiolo-
gical (e.g. menstrual cycle, pregnancy)
and nonphysiological conditions (e.g.
hormone therapy, use of oral contra-
ceptives). The effects of these treat-
ments on the periodontium have been a
center of focus for understanding the
interaction between sex hormones and
periodontium health (Soory 2000b).
Contraceptives
Hormonal contraceptives induce a hor-
monal condition that stimulates a state
of pregnancy to prevent ovulation by
the use of gestational hormones. Oral
contraceptive agents are one of the most
commonly used classes of drugs. The
most commonly used contraceptives
nowadays consist of low doses of
estrogens (30mg/day) and/or Progestins
(1.5mg/day) (Chihal et al. 1975, Brown
et al. 2001, 2002).
The influence of contraceptives on
the periodontium is not limited to
increases in inflammation and in the
amount of gingival exudates (Lindhe &
Bjorn 1967, Lynn 1967, Groen et al.
1968, el-Ashiry et al. 1971, Knight &
Wade 1974, Pankhurst et al. 1981).
These drugs have also been associated
with an increase in the prevalence of dry
socket after dental extraction (Catellani
1979), and accelerated progression of
periodontal disease (higher gingival
index scores and more loss of attach-
ment) when they are used long-term. In
contrast, some authors have found no
significant influences on the periodontal
clinical parameters when comparing
oral contraceptives to non-medicated
control groups (Moshchil et al. 1991).
Hormone replacement therapy in
postmenopausal women
Osteoporosis, which is defined as a
systemic condition characterized by a
decrease in the bone mineral density of
at least 2.5 times the normal values in a
healthy young female, is a major health
problem in postmenopausal women. In
Western societies, more than one-third
of the female population above the age
of 65 years suffers from signs and
symptoms of osteoporosis, a disorder
characterized by low bone mass. Estro-
gen deficiency is the dominant patho-
genic factor for osteoporosis in women
(Reinhardt et al. 1999). Although hor-
monal replacement in an adequate
dosage can slow or prevent bone loss
(Ettinger 1993, Allen et al. 2000), only a
small percentage of postmenopausal
women receive such therapy, and many
who do fail to comply with the pre-
scribed regimen because of the fear of
cancer, irregular bleeding, and other
minor side effects (Bjorn & Backsrom
1999, Bai et al. 2000, Kenemans et al.
2001, Schneider 2001).
Progesterone alone is not effective in
preventing postmenopausal bone and
tooth loss (Ettinger 1988, Jeffcoat
1998), but when combined with estro-
gen it is believed to uncouple formation
and resorption to diminish bone resorp-
tion induced by estrogen (Christiansen
et al. 1985).
Paganini-Hill (1995a) analyzed the
effects of estrogen replacement therapy
(ERT) on the prevention of tooth loss
and the need for dentures in older
women. Results from this study indi-
cated that the proportion of edentulous
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women decreased with increasing dura-
tion of ERT. The author therefore
concluded that ERT may be beneficial
in preventing tooth loss and the need for
dentures in older women
Reinhardt et al. (1999) analyzed pro-
spectively the influence of serum estra-
diol (E2) levels and osteopenia/osteo-
porosis on common clinical measure-
ments of periodontal disease over a 2-
year period. E2 status, which was condi-
tioned by the presence of ERT, did not
influence the percentage of sites losing
clinical attachment level for either per-
iodontitis or nonperiodontitis groups, but
when nonsmoking osteopenic/osteoporo-
tic periodontitis patients were evaluated,
E2-deficient subjects had more BOP and
a trend toward a higher frequency of
X2.0mm clinical attachment loss than
E2-sufficient subjects. These data suggest
that E2 supplementation (serum E2440pg/
ml) is associated with reduced gingival
inflammation and a reduced frequency
of clinical attachment loss in osteope-
nic/osteoporotic women in early meno-
pause.
Other than just having a positive
effect on the alveolar and skeletal bone
density, hormonal replacement therapy
may have other positive effects such as
reduction of the risk of fatal and
nonfatal myocardial infarction, is-
chemic heart disease, and stroke by
20–40%, and even a reduction in the
prevalence of Alzheimer’s disease (Pa-
ganini-Hill 1995b, c).
The available data indicate that hor-
mone replacement therapy should be
suggested for women during menopause
since several pathologic conditions com-
mon during this period of time can be
avoided or at least reduced in severity.
Influence of Sex Hormones on
Periodontal/Implant Wound Healing
The effects of sex hormones in the
wound healing of different organs have
been studied and, in some cases, proved.
Even though the direct effect of these
hormones in periodontal wound healing
is still far from being completely studied
and clarified, other systems like the brain
(Chowen et al. 2000) and the ligaments
(Frank et al. 1999) are already known to
be targets for sex hormones during the
wound healing processes. At a molecular
level, research has also shown that sex
hormones have a regulatory effect on
growth factors involved in the wound
healing such as the keratinocyte growth
factor (Rubin et al. 1995), which has
been known to have wound healing
regulatory effect including stimulation
of proliferation, migration, and morpho-
genesis of pluripotential cells.
However, the influence of sex hor-
mones on periodontal wound healing is
still largely unknown. As discussed
above, people with hormone deficiencies
may show more periodontal disease/
destruction. However, the mechanisms
of how this occurs remain to be
determined. Overall, lack of sex hor-
mones often causes the reduction of bone
density (Reinhardt et al. 1999). There-
fore, some authors consider the osteo-
porotic status a risk factor for implant
success (Roberts et al. 1992) and others
disagree. For example, Cuenin et al.
studied the association between sex
hormone levels and dental implant
success in three patient groups: (1) male
controls, (2) females with high estrogen,
and (3) females with low estrogen. They
found that the balance of alveolar
osseous wound healing was not influ-
enced by temporal fluctuations of the
ovulatory cycle (Cuenin et al. 1997).
More research is definitely needed to
improve the understanding of how sex
hormones influence the overall period-
ontal and implant wound healing.
Conclusion
Sexual hormones play an important role
in influencing periodontal disease pro-
gression and wound healing. These
effects are different depending on the
gender as well as the lifetime period
analyzed. It is also clear that not all
patients and their periodontium respond
in the same way to similar amounts of
circulating sexual hormones.
In addition, the influence of sex
hormones can be minimized with good
plaque control as well as with hormone
replacement therapies; however, the
true mechanism of how these interac-
tions actually occur remains to be
determined.
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Zusammenfassung
Einfluss von Sexualhormonen auf das Parodon-
tium
Männliche und weibliche Sexualhormone wur-
den schon lange einen wichtigen Einfluss auf
das parodontale Gewebe, die Knochenumsatz-
rate, die Wundheilung und die parodontale
Erkrankungsprogression ausübend betrachtet.
Der Einfluss dieser Hormone auf das Parodon-
tium unterscheidet sich zu verschiedenen phy-
siologischen Phasen (z.B. Pubertät,
Schwangerschaft, post Menopause) und mit
der Einnahme von Pharmaka (z.B. Antikonzep-
tiva, Hormonsubstitution). Deshalb ist der
Zweck dieses Reviewartikels (1) die Beziehung
zwischen Sexualhormonen und dem Parodon-
tium zu beschreiben, (2) die Analyse des
Einflusses dieser Hormone auf das Parodontium
zu unterschiedlichen Lebenszeiten und (3) die
Effekte von Hormonunterstützung/substitution
auf das Parodontium zu diskutieren.
Résumé
Influence des hormones sexuelles sur le par-
odonte
On a longtemps considéré que les hormones
sexuelles, aussi bien masculines que féminines,
jouaient un rôle important sur les tissus
parodontaux, le taux de remaniement osseux,
la cicatrisation et la progression de la maladie
parodontale. L’influence de ces hormones sur le
parodonte est différente en fonction des divers
conditions physiologiques (par exemple, la
puberté, la grossesse, et après la ménopause)
et les prises de médicaments (par exemple, la
pillule contraceptive et les traitements hormo-
naux de substitution). Aussi, cette revue critique
de la littérature se propose (1) de faire le point
sur les liens entre les hormones sexuelles et le
parodonte (2) d’ analyser la façon dont ces
hormones influencent le parodonte lors des
différentes étapes de la vie , et (3) discuter les
effets des hormones de substitution sur le
parodonte.
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